No, though her focus on the scourge of HIV (and her optimism) is highlighted. She reiterated that as it currently stands, once on HIV treatment, the treatment is for life.
No way she'd mention anything price sensitive and commercially-focused companies or drugs at the development stage.
Dr Lewin was a consultant for Biotron's BIT225.
